DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 968 filers reported holding DANAHER CORPORATION in Q1 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $43,122,611 | -1.7% | 172,594 | -1.8% | 0.21% | -10.0% |
Q1 2024 | $43,875,804 | -37.0% | 175,700 | -41.6% | 0.23% | -36.7% |
Q4 2023 | $69,646,758 | -3.8% | 301,058 | +3.2% | 0.36% | -16.4% |
Q3 2023 | $72,406,496 | +4.9% | 291,844 | +1.5% | 0.43% | +9.1% |
Q2 2023 | $68,995,680 | +20.5% | 287,482 | +26.6% | 0.40% | +9.4% |
Q1 2023 | $57,252,146 | -3.1% | 227,155 | +2.0% | 0.36% | -12.9% |
Q4 2022 | $59,090,455 | -99.9% | 222,630 | +12.8% | 0.42% | +6.1% |
Q3 2022 | $50,975,340,000 | +4.8% | 197,357 | +2.9% | 0.39% | +14.9% |
Q2 2022 | $48,632,995,000 | -10.0% | 191,831 | +4.1% | 0.34% | +6.5% |
Q1 2022 | $54,052,506,000 | -7.8% | 184,272 | +3.4% | 0.32% | -6.7% |
Q4 2021 | $58,614,448,000 | +10.2% | 178,154 | +2.0% | 0.34% | -0.3% |
Q3 2021 | $53,181,406,000 | +11.4% | 174,686 | -1.8% | 0.34% | +9.2% |
Q2 2021 | $47,736,145,000 | +17.5% | 177,881 | -1.4% | 0.32% | +6.8% |
Q1 2021 | $40,614,336,000 | -0.2% | 180,444 | -1.5% | 0.30% | -17.1% |
Q4 2020 | $40,713,597,000 | +141.9% | 183,279 | +134.5% | 0.36% | +99.4% |
Q3 2020 | $16,827,394,000 | +31.3% | 78,147 | +7.8% | 0.18% | +18.5% |
Q2 2020 | $12,820,175,000 | +42.9% | 72,500 | +11.8% | 0.15% | +14.4% |
Q1 2020 | $8,974,228,000 | -24.4% | 64,838 | -16.2% | 0.13% | +12.8% |
Q4 2019 | $11,870,757,000 | +18.4% | 77,344 | +11.4% | 0.12% | +3.5% |
Q3 2019 | $10,025,608,000 | +10.4% | 69,415 | +9.3% | 0.11% | +7.6% |
Q2 2019 | $9,080,422,000 | +1.3% | 63,535 | -6.5% | 0.10% | +2.9% |
Q1 2019 | $8,966,666,000 | +16.4% | 67,919 | -9.0% | 0.10% | +2.0% |
Q4 2018 | $7,700,280,000 | -12.0% | 74,673 | -7.2% | 0.10% | +2.0% |
Q3 2018 | $8,747,456,000 | +14.4% | 80,503 | +3.9% | 0.10% | +8.9% |
Q2 2018 | $7,643,259,000 | +7.7% | 77,455 | +6.9% | 0.09% | +5.9% |
Q1 2018 | $7,094,069,000 | +14.3% | 72,455 | +8.4% | 0.08% | +13.3% |
Q4 2017 | $6,205,481,000 | +9.9% | 66,855 | +1.5% | 0.08% | 0.0% |
Q3 2017 | $5,649,042,000 | -1.8% | 65,855 | -3.4% | 0.08% | -10.7% |
Q2 2017 | $5,751,600,000 | -1.8% | 68,155 | -0.4% | 0.08% | -8.7% |
Q1 2017 | $5,854,956,000 | +25.5% | 68,455 | +14.2% | 0.09% | +7.0% |
Q4 2016 | $4,666,897,000 | +2.5% | 59,955 | +3.3% | 0.09% | -4.4% |
Q3 2016 | $4,550,931,000 | -29.0% | 58,055 | -8.5% | 0.09% | -33.8% |
Q2 2016 | $6,408,955,000 | +11.2% | 63,455 | +4.4% | 0.14% | +13.3% |
Q1 2016 | $5,763,219,000 | +55.3% | 60,755 | +52.1% | 0.12% | +50.0% |
Q4 2015 | $3,711,020,000 | +6.1% | 39,955 | -2.7% | 0.08% | -8.0% |
Q3 2015 | $3,498,297,000 | +0.3% | 41,055 | +0.7% | 0.09% | +13.0% |
Q2 2015 | $3,488,220,000 | +3.3% | 40,755 | +2.5% | 0.08% | +2.7% |
Q1 2015 | $3,375,200,000 | +8.6% | 39,755 | +9.7% | 0.08% | +7.1% |
Q4 2014 | $3,107,416,000 | +23.4% | 36,255 | +9.4% | 0.07% | +27.3% |
Q3 2014 | $2,519,117,000 | +1.7% | 33,155 | +5.4% | 0.06% | +5.8% |
Q2 2014 | $2,476,452,000 | +229.1% | 31,455 | +189.8% | 0.05% | +147.6% |
Q3 2013 | $752,469,000 | – | 10,855 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |